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Abstract Group A Streptococcus is a leading human
pathogen associated with a diverse array of mucosal and
systemic infections. Cell wall anchored pili were recently
described in several species of pathogenic streptococci, and
in the case of GAS, these surface appendages were
demonstrated to facilitate epithelial cell adherence. Here
we use targeted mutagenesis to evaluate the contribution of
pilus expression to virulence of the globally disseminated
M1T1 GAS clone, the leading agent of both GAS
pharyngitis and severe invasive infections. We confirm that
pilus expression promotes GAS adherence to pharyngeal
cells, keratinocytes, and skin. However, in contrast to
findings reported for group B streptococcal and pneumo-
coccal pili, we observe that pilus expression reduces GAS
virulence in murine models of necrotizing fasciitis, pneu-
monia and sepsis, while decreasing GAS survival in human
blood. Further analysis indicated the systemic virulence
attenuation associated with pilus expression was not related
to differences in phagocytic uptake, complement deposition
or cathelicidin antimicrobial peptide sensitivity. Rather,
GAS pili were found to induce neutrophil IL-8 production,
promote neutrophil transcytosis of endothelial cells, and
increase neutrophil release of DNA-based extracellular
traps, ultimately promoting GAS entrapment and killing
within these structures.
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Streptococcus pyogenes (group A Streptococcus (GAS)) is
a leading human pathogen estimated to cause over 500,000
deaths each year globally, with disproportionate effects
upon children, the elderly, and those living in developing
countries [1, 2]. While GAS can asymptomatically colonize
the upper respiratory tract or skin of healthy individuals, it
is also associated with a large spectrum of mucosal and
invasive diseases, from simple pharyngitis or impetigo to
the potentially life-threatening pneumonia, necrotizing
fasciitis (NF) and toxic shock syndrome (TSS) [3]. A
resurgence of severe GAS disease in recent decades has
been mirrored by the emergence of a globally disseminated
clone of the M1T1 serotype [4]. M1T1 strains are the most
common cause of GAS pharyngitis and are strongly
overrepresented in severe cases such as NF and TSS [5].
The ability of GAS to produce life-threatening infections
even in previously healthy people reflects a diverse array of
surface-associated and secreted virulence factors that
together allow the bacterium to invade host cellular
barriers, resist innate immune clearance, injure host tissues,
and provoke harmful or dysregulated inflammatory
responses [6, 7]. Remarkably, only in recent years was it
recognized that major hair-like oligomeric surface organ-
elles known as pili were present on the surface of Gram-
positive bacteria including the pathogenic streptococci
GAS, group B Streptococcus (GBS), and Streptococcus
pneumoniae [8]. Targeted mutagenesis coupled with tissue
culture assays and murine infection models have indicated
that both GBS and pneumococcal pili each contribute to
disease pathogenesis, but in different manners. Both pilus
structures promote cell adherence and invasion [9, 10];
however, while GBS pili aid in resistance to host
antimicrobial peptide and neutrophil killing mechanisms
[11], pneumococcal pili stimulate exaggerated proinflam-
matory responses including tumor necrosis factor-α (TNF-α)
release [9].
The role of the GAS pilus structure in disease patho-
genesis has not been studied extensively in vivo. GAS pili
are encoded by a highly variable locus known as the
fibronectin-binding, collagen-binding T antigen (FCT)
region. In M1 strains, this pathogenicity island encodes
RofA, a transcriptional regulator, Cpa, a collagen-binding
protein [12], Spy0128, the pilus backbone subunit,
Spy0125 and Spy0130, two pilus accessory proteins, and
Spy0129 (SrtC1), a sortase enzyme that polymerizes the
GAS pilus proteins via covalent linkage. GAS pilus
assembly requires expression of Spy0128 and SrtC1, but
not the other genes. Interestingly, Spy0128 is now
recognized to represent the classical Lancefield T1 antigen
[13], a variable trypsin-resistant surface protein used for
decades along with M protein for GAS typing schema
based on serum recognition [14]. Deletion of Spy0128
suggests that GAS pili can contribute to biofilm formation
[15] and bacterial aggregation in saliva [16], as well as
adherence to human tonsil explants and some but not all
human epithelial cell lines tested [15, 17]. In the M53
serotype background, full-length GAS pili were not
required for disease establishment in a humanized mouse
model of impetigo [18].
In this study, we generate a targeted deletion of the
Spy0128 major pilus backbone subunit in a representative
isolate of the M1T1 GAS clone, originally isolated from a
patient with NF and TSS, to study the role of pili in disease
pathogenesis using several in vitro and in vivo model
systems. While pili are seen to promote GAS colonization
phenotypes, they are found to restrict invasive disease
pathogenesis, in direct contrast to findings reported for
GBS and pneumococcal pili. A novel association with
neutrophil extracellular killing mechanisms may help
explain this unexpected finding.
Methods
Bacterial strains, mutagenesis, and complementation
WT GAS M1T1 strain 5448 was isolated from a patient
with NF and TSS [19]. GAS were propagated in Todd–
Hewitt broth (THB) or on THB agar (THA; Difco, BD,
Franklin Lakes, NJ, USA). Precise allelic replacement of
the spy1028 gene was performed using an established
methodology [20]. Briefly, ~1,000 bp of flanking DNA
immediately upstream and downstream of the spy1028 gene
was amplified from the M1T1 chromosome by PCR using
primers with 25 bp extensions corresponding to the 5′ and
3′ end of the chloramphenicol acetyltransferase (cat) gene.
The upstream and downstream PCR products were then
joined with the cat gene (from plasmid pACYC1094) by
fusion PCR, and the resultant amplicon, containing an in-
frame substitution of spy1028 with cat, was subcloned into
the temperature-sensitive suicide vector pHY304 to yield
the knockout vector pSpy1028-KO. This vector was
introduced into GAS M1T1 strain 5448 by electroporation
and single and double crossover events identified by
differential temperature and antibiotic sensitivity, using
5 μg/ml erythromycin (Erm) and 2 μg/ml chloramphenicol
(Cm) for selection. The isogenic mutant 5448ΔPil was
confirmed unambiguously by PCR and sequence analysis
to contain a precise chromosomal replacement of spy1028
with cat. For complementation analysis, the full-length
spy0128 gene was amplified from the GAS M1T1 5448
genome, subcloned into the streptococcal expression vector
pDCerm [20], and introduced into the 5448ΔPil mutant
using Erm selection; an empty vector control strain was
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strains exhibited equivalent growth kinetics in THB and
RPMI-1640 media used in our tissue culture assays (data
not shown).
Detection of pilus expression via immunofluorescent
microscopy
Logarithmic-phase GAS were plated on Polysine micro-
scope slides (Eerie Scientific) and fixed with 3% parafor-
maldehyde (PFA). Slides were blocked with 3% bovine
serum albumin (BSA) in PBS containing 0.05% Tween-20
(blocking buffer) overnight at 4°C in a humidified chamber.
Slides were incubated with goat serum diluted 1:200 in
blocking buffer, followed by incubation with primary rabbit
antisera against the GAS T1 antigen, i.e., Spy1028
(obtained from Centers for Disease Control Streptococcal
Laboratory, Atlanta, GA), diluted 1:1,000 in blocking
buffer. The slides were then incubated with a secondary
fluorescein isothiocyanate (FITC)-conjugated goat anti-
rabbit IgG diluted 1:200 in blocking buffer. Mounted
samples were viewed simultaneously with a ×60/1.42
PlanApo objective after laser excitation at 488 nm and
differential interference contrast using a spectral deconvo-
lution confocal microscope (Olympus FV1000).
Epithelial cell adherence assays
Bacterial adherence to epithelial cells was determined as
previously described [21]. Briefly, human pharyngeal
epithelial cells (HEp-2) and skin keratinocytes (HaCaT)
obtained from ATCC were propagated as monolayers in
RPMI-1640+10% fetal bovine serum (FBS), 2 mM L-
glutamine, and 100 μM nonessential amino acids at 37°C+
5% CO2. For adherence assays, cells were plated at 2×10
5
cells/well in a tissue culture-treated 24-well plate and
incubated at 37°C overnight. Then 2×10
6 colony forming
units (CFU) of logarithmic phase GAS (multiplicity of
infection=MOI=10:1) in fresh RPMI-1640+2% FBS were
added to each well. The plate was centrifuged at 1600 RPM
for 5 min, then incubated at 37°C+5% CO2 for 30 min.
Monolayers were washed with PBS to remove unattached
bacteria, and 100 μl of trypsin and 400 μl of 0.025%
Triton-X 100 were added to each well to facilitate cell
detachment and lysis. Dilutions were plated on THB at
37°C overnight for enumeration of CFU.
Skin adherence assay
Eight-week-old female CD-1 mice (Charles River Labora-
tories, CA) were shaved and treated with Nair® (Church &
Dwight Co., Inc.) 24 h prior to infection. Logarithmic phase
WT and ΔPil mutant GAS were mixed 1:1 in PBS and
10 μL drops containing 1×10
6 total CFU plated on THA.
Six-mm skin biopsy punches (Acuderm Inc.) were used to
cut out disks of agar. Mice were sedated with ketamine/
xylazine intraperitoneally (i.p.). Agar disks were placed
onto mouse skin for 1 h to allow bacterial adherence;
control agar disks were added to 2 mL Micro-tubes
(Sarstedt) on ice. Skin around the periphery of the agar
disks was marked and agar disks gently lifted off and
discarded. Skin within the marked perimeter was harvested
using 8-mm skin biopsy punches and placed in 2 mL
Micro-tubes containing 1 mL of PBS on ice. Tubes
containing skin were placed in the Mini Bead Beater
(Biospec Products, Inc.) and gently shaken on “wash”
setting for 1 min, supernatant was discarded, and 1 mL of
fresh PBS was added. Skin was washed again for 1 min,
supernatant was discarded, and 1 mL of PBS with 1 mm
Zirconia/Silica beads (Biospec Products, Inc.) was added to
these tubes and control agar tubes. Skin and agar controls
were homogenized for 2 min, serially diluted, and replica
plated on THA (for enumeration of all bacteria) and THA+
2 μg/mL Cm (for enumeration of ΔPil alone).
Animal infection models
Eight- to ten-week-old female CD-1 mice were used for all
experiments. Necrotizing subcutaneous infection was
studied using a well-established model [21–23]. Briefly,
logarithmic phase GAS were diluted 1:1 with sterile
Cytodex beads (Sigma). Eight- to ten-week-old female
CD-1 mice were shaved and Nair® applied 24 h prior to
infection. Mice were injected subcutaneously in the left
f l a n kw i t h5 × 1 0
7 WT or ΔPil+Pil complemented mutant
GAS and simultaneously in the right flank with an
equivalent inoculum of the isogenic ΔPil mutant, allowing
each mouse (N=8) to serve as its own control. Developing
lesion sizes were measured daily, and on d4 mice were
euthanized, skin lesions excised, homogenized, and seri-
ally diluted for plating on THA and enumeration of CFU.
Pneumonia was modeled by introducing 1×10
8 CFU WT
or isogenic ΔPil mutant GAS into the left nare of mice
held in the upright position. At 24 or 48 h, mice were
euthanized with inhaled CO2. The right lung was
homogenized, serially diluted, and plated on THA for
enumeration of total CFU. The left lung was inflated with
4% PFA for 5 min, resected, and placed in PFA for
histology. Hematoxylin-eosin-stained lung sections were
evaluated under light microscopy at ×10, ×40, and ×100
using a Zeiss Axiolab microscope. Systemic sepsis was
modeled by injecting 2×10
8 CFU logarithmic phase WT
or isogenic ΔPil mutant GAS in 100 μLo fP B Sv i at a i l
vein; mice were then monitored twice daily for mortality
(N=11 or 12 animals per group total from two separate
experiments).
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killing assays
For whole blood killing assays, a phlebotomy sample was
obtained from a healthy human volunteer and 300 μL
placed in each 2-mL siliconized tube (Fisher Scientific).
Next, 100 μL of logarithmic phase GAS was added to reach
a final concentration of 1×10
4 CFU/mL. Tubes were
incubated on a tube rotator at 37°C. At 2 h, blood was
serially diluted and plated on THA for enumeration of
CFU. For J774 murine macrophage killing assays, cells
were plated at 7.5×10
5 cells/well in RPMI-1640+2% FBS
in a 24-well plate and incubated at 37°C+5% CO2
overnight. Then 7×10
6 CFU of logarithmic phase GAS
were added to each well and the plates were incubated for
30 min at 37°C+5% CO2. Cells were rinsed with PBS,
detached and lysed with 0.025% Triton X-100, serially
diluted, and plated on THA for enumeration of total cell-
associated CFU. For cathelicidin antimicrobial peptide
killing assays, GAS were grown to logarithmic phase,
brought up at 1×10
5 CFU/mL in 70% DMEM+10%FBS+
20%THB, and 90 μL was added to 10 μL of varying
concentrations of human (LL-37) or mouse (CRAMP)
cathelicidin in triplicate wells in a 96-well plate, then
incubated for 24 h at 37°C. Bacteria were plated on THA to
determine the MIC for each peptide.
Complement deposition
Human serum was isolated from whole blood by coagula-
tion in glass serum tubes (BD Biosciences) and stored
at −80°C. Normal human serum (nhs) was generated by
pooling sera from six different donors. To inactivate
complement, nhs was heat-inactivated at 56°C for 30 min.
GAS were grown to logarithmic phase and washed with
HEPES-buffered saline containing 5 mM CaCl2 and
2.5 mM MgCl2 (HBS
++)+1% BSA (HBS
++–BSA). Bacte-
ria were diluted ×200 and incubated with nhs at 0%, 2%,
5%, and 10% for 20 min at 37°C in a fast shaker. Bacteria
were washed and incubated with FITC-conjugated anti-
human C3 antibodies (Protos Immunoresearch) on ice for
30 min. Washed bacteria were taken up in PBS and
analyzed on BD FACSCalibur flow cytometer, using BD
CellQuest Pro, and data were analyzed with FlowJo (Tree
Star, Inc.). Fluorescent mean, median, and geometric mean
were obtained from all samples.
Neutrophil endothelial transcytosis assays
Human brain endothelial cells were propagated as mono-
layers in RPMI-1640+10% FBS and human lung endothe-
lial cells (kind gift of Dr. Jeffrey Esko) were propagated as
monolayers in DMEM (low glucose ×1; Mediatech) +20%
FBS+1% nonessential amino acids+50 μg/mL heparin at
37°C+5% CO2. Transwells (Costar) were placed inside
tissue culture-treated 24-well plates, with 500 μL of media
in the lower chambers. Cells were plated at 5×10
5 cells/
upper chamber in 150 μL of media and incubated at
37°C+5% CO2 until confluent monolayers formed. Next,
1×10
6 CFU of logarithmic phase WT, ΔPil+Pil comple-
mented mutant, or ΔPil mutant were added to each lower
chamber and 1×10
6 fresh human neutrophils were added to
each upper chamber. At indicated time-points, the media in
lower chambers was gently agitated, 30-μL samples
removed, and the total number of neutrophils migrating to
the lower chamber quantified with a hemocytometer under
light microscopy.
Neutrophil IL-8 release and phagocytosis assays
To measure neutrophil interleukin-8 (IL-8) release, 1×10
5
human neutrophils were infected with 1×10
4 CFU of
logarithmic phase GAS. At 3 h, 200 μL of media was
removed and spun at 1,400 RPM, and the supernatant
frozen at −20°C. Quantitative ELISA for IL-8 was per-
formed using an IL-8 Quantikine kit (R&D Systems)
according to the manufacturer’s instructions, using samples
thawed on ice and diluted 1:4 in ELISA buffer. To assess
neutrophil phagocytosis, GAS were labeled with FITC
through a modified protocol derived from Goldmann et al.,
2004 [24]. Logarithmic-phase GAS were concentrated in
PBS to OD600 of 1.0, FITC was added to a final
concentration of 0.2 mg/mL, and samples incubated for
30 min, on ice, in the dark. Bacteria were washed with PBS
until the supernatant was clear, then 1×10
6 CFU were
added to 1×10
5 neutrophils (MOI 10:1) in RPMI-1640+
2% FBS. Samples were incubated for 60 min at 37°C.
Trypan blue was added for a final concentration of 0.5% to
quench extracellular fluorescence. Samples were rinsed
with PBS and then run on BD FACSCalibur flow
cytometer, using BD CellQuest Pro, and data was analyzed
with FlowJo (Tree Star, Inc.). Fluorescent mean, median,
and geometric mean were obtained on all samples.
Neutrophil extracellular trap assays
To assess neutrophil extracellular trap (NET) induction,
coverslips (1/2 oz, 12 mm; Fisher) were coated with Poly-
D-lysine (Sigma) and placed in 24-well ultra low attachment
surface plates (Costar) with 500-μL RPMI-1640+2% heat-
inactivated human serum. Human neutrophils were plated
at 5×10
5 per well, infected with 5×10
4 CFU logarithmic-
phase GAS, and spun at 1,600 RPM for 10 min prior to
incubation at 37°C+5% CO2 for 20 min. PFAwas added to
final concentration of 4% and coverslips were inverted into
ProLong® Gold with DAPI (Invitrogen). NETs were
374 J Mol Med (2010) 88:371–381visualized and quantified per visual field using a ×40/0.65
Achroplan objective with a Zeiss Axiolab fluorescent
microscope. For NET adherence and killing assays,
neutrophils were incubated with 25 nM phorbol myristate
acetate (PMA) for 4 h to maximally induce NETs and
eliminate phagocytosis. NETs were infected with GAS and
spun at 1,600 RPM for 10 min. To quantify adherence,
NETs and bacteria were incubated at 37°C+5% CO2 for
5 min. NETs were gently rinsed with PBS, then harvested
with 0.025% Triton X-100, serially diluted, and plated on
THA for enumeration of total NET-associated CFU. For
killing assays, NETs and bacteria were incubated at 37°C+
5% CO2 for 20 min. NETs and bacteria were harvested with
0.025% Triton X-100, serially diluted, and plated on THA
for enumeration of total cell-associated CFU. In both
adherence and killing assays, at the end of their respective
incubations, two wells of each condition were treated with
LIVE/DEAD BacLight staining (Molecular Probes), fixed
with 1% PMA, mounted onto glass slides using ProLong®
Gold with DAPI and immediately visualized under fluores-
cent microscopy.
Statistical analysis
Differences in bacterial counts were evaluated by Student’s
t test. Significance was determined as P<0.05. Survival
curves were evaluated by the Wilcoxon’s rank-sum test.
Assurances
Human blood collection and neutrophil isolation were
approved by the University of California San Diego
(UCSD) Human Research Protections Program. Animal
studies were approved by the UCSD Institutional Animal
Use and Care Committee.
Results
Mutagenesis and complementation of pilus expression
in GAS strain M1 5448
To explore the functional role of pili in the pathogenesis of
invasive M1T1 GAS disease, a knockout mutant (ΔPil) of
strain 5448 was generated by precise allelic exchange
mutagenesis of spy0128, then complemented by return of
the spy0128 gene on an expression plasmid. To confirm
functional changes in GAS pilus expression, we performed
immunofluorescent labeling against Spy0128. Whereas
surface pili were observed in the WT GAS parent strain
and the complemented mutant, no pili were detected on the
surface of the ΔPil mutant (Fig. 1a).
Pili contribute to GAS M1T1 epithelial cell adherence
in vitro and skin adherence in vivo
Adherence phenotypes were assessed in cell lines represen-
tative of the two principal sites of GAS colonization.
Compared to the WT GAS parent strain, the isogenic ΔPil
mutant showed an 87% reduction in adherence to HaCaT
human keratinocytes (P<0.001; Fig. 1b), a defect that was
partially restored in the complemented mutant (P<0.005),
and a 28% reduction in adherence to HEp-2 human
pharyngeal epithelial cells (P<0.05); although the observed
partial complementation (~12%) of the latter defect did not
reach statistical significance. To assess the role of pili in
GAS adherence to intact skin, a competition experiment
was performed in which a 1:1 mixture of WT and ΔPil
mutant GAS was inoculated on mouse skin for 1 h before
harvesting and bacterial enumeration. Control sample
mixtures were plated to confirm the initial inoculum. WT
GAS outcompeted the isogenic ΔPil mutant, as demon-
strated by a ratio of greater than 1 in all samples. The
Fig. 1 Targeted deletion of the spy0128 gene eliminates pilus
expression and reduces GAS adherence to human epithelial cells and
mouse skin. a Green fluorescent immunostaining with anti-T1 antigen
(Spy0218) antisera is positive for WT GAS, negative for the isogenic
ΔPil mutant, and restored in the ΔPil+Pil complemented strain. b
GAS WT and ΔPil+Pil complemented strains are more adherent to
keratinocytes and epithelial cells compared with the ΔPil mutant,
*P<0.05. c GAS WT outcompetes ΔPil in adherence to mouse skin;
circles represent the ratio of GAS WT CFU to ΔPil mutant CFU
recovered for individual skin lesions, bar represents the mean. In
vivo experiments were repeated three times, representative experi-
ment shown
J Mol Med (2010) 88:371–381 375median ratio of WT:ΔPil bacteria recovered was >6:1 in the
excised skin samples (P<0.02; Fig. 1c).
Pilus expression blunts M1T1 GAS virulence in three
different murine infection models
The contribution of pilus expression to GAS invasive
disease pathogenesis was tested in three different model
systems of infection, providing surprising but internally
consistent results. First a subcutaneous injection model was
used, in which GAS M1T1 produces necrotizing lesions or
ulcers with histopathologic features resembling human NF.
Compared to the WT GAS parent strain, the isogenic ΔPil
mutant produced significantly larger lesions by d2 and d3
post-infection (P<0.02; Fig. 2a; representative mouse
shown in Fig. 2c), while the complemented mutant (ΔPil+
Pil) mutant had significantly smaller lesions on d3 post-
infection than ΔPil harboring an empty vector control (P<
0.02; Fig. 2b). Next, GAS pneumonia was established in
mice by intranasal inoculation and lungs harvested at 24 or
48 h. We found significantly more bacteria were recovered
from lungs of mice infected with the GAS ΔPil mutant than
the WT parent strain at either time point (P<0.04; Fig. 3a).
By 24 h, histopathology reflected the increased bacterial
burden in the lungs of ΔPil-infected mice, and by 48 h,
markedly more severe pneumonia with dense neutrophilic
infiltration was evident in the ΔPil-infected mice vs. the WT
GAS-infected mice (Fig. 3b). Finally, we modeled GAS
sepsis by injecting the bacteria intravenously and monitoring
mortality. In this study, the ΔPil mutant GAS demonstrated
more rapid kinetics of lethality (50% dead by 72 h vs 96 h
for the WT strain; 100% mortality in 96 h vs. 144 h for the
WT strain, P=0.002, Fig. 3c). Thus in three distinct models
of invasive M1T1 GAS infection, we observed pilus
expression to diminish virulence potential, a finding opposite
to those reported for the GBS or pneumococcal pili in
systemic mouse infection models.
Pilus expression increases GAS susceptibility to human
whole blood killing
To extend our animal observations to interactions with
components of the human innate immune system, we
assessed the contribution of pilus expression to M1T1
GAS survival in freshly drawn human blood. Consistent
with diminished systemic virulence in the mouse studies,
we found the ΔPil mutant had a 50% increase in blood
survival compared with WT GAS parent strain (P<0.001);
survival was reduced toward WT levels in the ΔPil+Pil
complemented mutant (P<0.02; Fig. 4a). However, in
contrast to findings reported for the GBS pili [11], GAS
pilus expression did not alter the bacterium’s susceptibility
to killing by the human cathelicidin antimicrobial peptide
LL-37 (MIC=32 μM for both WTand ΔPil mutant) nor the
murine cathelicidin antimicrobial peptide mCRAMP (MIC
=16 μM for both strains). No difference was observed in
WT vs. ΔPil mutant GAS susceptibility to killing by J774
murine macrophages (Fig. 4b), and similar degrees of
complement C3b deposition were measured on the surface
of the WT and ΔPil mutant bacteria after incubation in
human serum (Fig. 4c). Consistent with equivalent levels of
C3b-mediated opsonization, human neutrophil phagocytotic
uptake of FITC-labeled WT, ΔPil mutant and ΔPil+Pil
complemented mutant bacteria was similar as assessed by
flow cytometry (Fig. 4d). Together these data indicate that
the attenuating effect of pilus expression on M1T1 GAS
virulence in the animal infection models or human blood
killing studies was not linked to increased neutrophil
opsonophagocytosis.
GAS pilus expression stimulates neutrophil IL-8 production
and endothelial transcytosis
An important property reported for pneumococcal pili is the
induction of increased levels of host pro-inflammatory
Fig. 2 Deletion of GAS pilus expression increases virulence in a
mouse model of necrotizing fasciitis. a Subcutaneous infection with
the ΔPil mutant generates larger skin lesions compared with GAS WT
at 48 h (P=0.014) and 72 h (P=0.013); representative mouse from
these experiments shown in c. b The ΔPil+Pil complemented mutant
produces smaller skin lesions than the ΔPil mutant at 72 h (P=0.011).
Eight mice were used per group and all experiments were repeated
three times with similar results
376 J Mol Med (2010) 88:371–381Fig. 3 Deletion of GAS pilus expression increases virulence in mouse
models of pneumonia and sepsis. a Mice infected intranasally with
GAS WT had significantly fewer bacteria in their lungs at 24 and
48 h. b Representative hematoxylin–eosin-staining of lung sections
demonstrates more histopathological damage in ΔPil lungs vs. WT-
infected lungs at 24 and 48 h. c Mice infected intravenously with the
ΔPil mutant died an average of 72 h after infection compared with
96 h after infection for WT-infected mice (P=0.002). The survival
curve was generated from pooling data from two experiments. At least
three mice were used per group and all experiments were repeated
three times
Fig. 4 Pilus expression in GAS leads to increased susceptibility to
whole blood killing and stimulates increased IL-8 release and
transendothelial migration by human neutrophils. a The ΔPil mutant
had increased survival in human whole blood compared with WT
GAS (P=0.0001) or the ΔPil+Pil complemented mutant (P=0.016). b
No difference in survival between piliated and non-piliated GAS
strains in a macrophage killing assay. c No difference in surface
deposition of complement component C3b in piliated vs. non-piliated
GAS. d Human neutrophils phagocytose FITC labeled GAS WT, ΔPil
mutant, and ΔPil+Pil complemented mutant strains with equivalent
efficiency. e Increased secretion of IL-8 by neutrophils exposed to WT
GAS vs. the ΔPil mutant (P=0.009). f Increased migration of
neutrophils through an endothelial monolayer in response to WT
GAS compared with the isogenic ΔPil mutant (P=0.03). All experi-
ments were performed in triplicate and were repeated three times;
representative experiment shown
J Mol Med (2010) 88:371–381 377cytokine expression [9]. IL-8 is a multifunctional human
innate defense protein with a key role in the recruitment
and activation of neutrophils [25]. IL-8 is produced in large
amounts by neutrophils upon detecting bacteria [26, 27]
and acts in an autocrine fashion to stimulate bactericidal
activities such as oxidative burst and release of granule
enzymes [28, 29]. To evaluate the effect of M1T1 GAS pili
on IL-8 production, freshly isolated human neutrophils
were exposed to GAS and IL-8 quantified by ELISA.
Neutrophils infected with the WT parent strain released ~35%
more IL-8 than those infected with the isogenic ΔPil mutant
(P<0.01; Fig. 4e). An established Transwell assay was
utilized to examine how the presence of pili influenced
human neutrophil endothelial transmigration toward the
pathogen. Human microvascular endothelial cells were
grown to confluence on a Transwell membrane, the lower
chambers inoculated with WT, ΔPil mutant or ΔPil+Pil
complemented mutant M1T1 GAS, and freshly isolated
human neutrophils added to the upper chambers. As shown
in Fig. 4f,t h eΔPil mutant GAS elicited the transmigration
of less than half as many neutrophils as the WT parent strain
(P<0.04); genetic complementation of the mutant partially
reversed the observed phenotype with a third more neutro-
phils transmigrating compared with the ΔPil mutant.
GAS pilus expression increases NET production
and the entrapment of GAS within these structures
Release of extracellular DNA-based antimicrobial traps has
recently been discovered as a new paradigm in the innate
immune function of neutrophils [30, 31]. This process is
morphologically distinct from other classical cell death
processes including apoptosis and necrosis, and has been
dubbed “NETosis” [32]. Binding of many species of
bacteria and fungi within the DNA backbone has been
demonstrated, and NETs contain cationic histones, granule
proteases, and antimicrobial peptides that together kill the
entrapped microbes [31, 33]. One of the proinflammatory
stimuli known to strongly activate NET production is
IL-8 [34, 35]. We found that human neutrophil exposure
to the WT GAS parent strain resulted in a more than 3-fold
increase in NET production as compared with treatment
with the ΔPil mutant (P<0.0001); NET induction was
restored to near WT levels in the ΔPil+Pil complemented
mutant (P<0.0001; Fig. 5a). Representative fluorescent
microscopy images showing increased NET production (red
arrows) by human neutrophils when infected with WT and
ΔPil+Pil GAS strains compared with infection with the
ΔPil mutant GAS are shown in Fig. 5b. Because GAS pilus
expression induced IL-8 production and NET release, and
because pili represent projecting structures that increase the
surface area of the bacterium, we hypothesized that piliated
GAS would have greater adherence to NETs and suscep-
tibility to NET killing. For equalization, neutrophils were
stimulated with PMA prior to allow maximal NET
production prior to GAS exposure. Significantly more WT
GAS and ΔPil+Pil complemented mutant GAS adhered to
NETs than did ΔPil mutant GAS (P<0.003; Fig. 5c).
Representative images of FITC-labeled GAS entrapped
within NETs, shown in Fig. 5d, demonstrate increased
entrapment of WT and ΔPil+Pil GAS compared with the
ΔPil mutant. Correspondingly, killing of GAS within the
induced NETs was significantly greater for WT GAS (78%
of inoculum) and ΔPil+Pil complemented mutant GAS
(99%) than the ΔPil mutant strain (55%; P<0.05; Fig. 5e).
Thus, we conclude that pilus expression enhances neutro-
phil extracellular clearance of GAS, through induction of
IL-8, activation of NET formation, and enhanced entrap-
ment of the bacterium within these structures.
Discussion
Through more than 50 years of research, the presence of
long, pilus-like polymers extending from the surface of
pathogenic streptococci went unrecognized. Now, a few
years after genome analyses inspired their discovery [9, 13,
36], streptococcal pili are appreciated to influence host cell
adherence, biofilm formation, interactions with the innate
immune system, and virulence potential [9–11, 15, 17, 18,
37–39]. In the present study, we use targeted mutagenesis
to examine the role of the major pilus subunit of GAS, now
recognized to represent the classical T antigen of this
species, in virulence phenotypes of the globally dissemi-
nated M1T1 clone that is the leading agent of pharyngitis
and invasive infections. While extending the tissue culture
results to demonstrate that GAS pili enhance adherence to
intact mouse skin, we find a surprising negative effect of
pili on invasive disease potential, which contrasts the
established virulence role of GBS and pneumococcal pili
in similar mouse models. Thus, the functional roles of pili
instreptococcal pathogenesis are not universal,but ratherbear
important species-specific attributes, such that generalizations
should not be assumed. Although similarities are identified
in the general genomic structure of streptococcal pilus gene
loci, including the presence of sortases for covalent linkage
of LP(X)TG sequence motifs in the major pilus subunits,
significant sequence diversity in the pilus genes themselves
would appear to allow for functional diversity of the
encoded proteins [8].
A validated model for development of invasive M1T1
GAS infection shows that innate immune-mediated selec-
tion of mutations in the covR/S two-component regulator
are a critical step in systemic dissemination of the pathogen
[40–44]. Such mutations lead to upregulation of key M1T1
GAS virulence factors that promote resistance to neutrophil
378 J Mol Med (2010) 88:371–381defenses, while allowing accumulation and activation of host
plasminogen on the bacterial surface, promoting tissue
spreading [42, 44]. Upon in vivo selection, two of the most
strongly upregulated GAS M1T1 genes, the IL-8 peptidase
SpyCEP and the phage-encoded DNAse Sda1, promote
resistance to NET-mediated killing, by blocking IL-8 stimu-
lation of NET production and by degrading the DNA
backbone of NETs, respectively [23, 35, 45]. Here we
identify GAS M1T1 pilus expression as instead promoting
susceptibility to NET-mediated killing, likely through in-
creased IL-8-dependent NET production coupled with
increased adherence to and physical entrapment within the
generated NETs. The GAS M1T1 pilus thus plays an
important role in virulence during establishment of infection
by increasing epithelial adherence, but may simultaneously
represent a pathogen-associated molecular pattern recognized
by phagocytes, promoting increased killing of GAS upon
arrival in blood or deeper tissues. Transcriptional analysis
indicates the M1T1 GAS spy1028 major pilus subunit gene
is slightly downregulated (by 1.2 fold) upon the in vivo
selected covR/S mutations [40], which would reduce its
contributions to NET generation and entrapment just as the
above-mentioned NET-resistance genes are upregulated.
The observed activation of host cytokine release for
GAS M1T1 was also reported for the pneumococcal pilus
[9]; Similarly, the P pili or type I pili of uropathogenic
Escherichia coli have been shown to stimulate IL-8 release
and induce migration of neutrophils across cellular barriers
[46, 47]. As we observed for the M1T1 GAS pilus, the
surface expressed GAS M1 protein was recently recognized
to stimulate NET production [48, 49], but M1 nevertheless
promotes GAS survival within these structures because it
reduces the bacterium’s susceptibility to human and murine
cathelicidin antimicrobial peptides present in NETs [48]. In
contrast, the GAS pilus was not observed to promote
cathelicidin resistance, a feature reported for pili of certain
strains of GBS [11].
Finally, though impeding invasive infection, our data
confirm that pilus expression is important for M1T1 GAS
adherence to human keratinocytes in vitro, as previously
reported [17], and we show that this phenotype is robust
enough to promote bacterial adherence to intact mouse
skin. Similarly, our finding that pili promote adherence to
human HEp-2 pharyngeal epithelial cells supports binding
studies performed with tonsillar explants [17]. Because
of the documented immunogenicity of the GAS pilus
(T antigen) in natural infection and mouse vaccination
studies [13, 15], the major pilus subunit Spy1028 continues
to represent an outstanding candidate GAS vaccine antigen,
with the potential to inhibit GAS colonization of the two
major epithelial surfaces (skin and pharynx) where it is
normally resident.
Fig. 5 GAS pilus expression stimulates neutrophil extracellular trap
(NET) release and increases GAS entrapment and killing within NETs.
a WT GAS (3.6 fold) and ΔPil+Pil complemented mutant (3.0 fold)
induce more NETs than the ΔPil mutant (P<0.0001). b Representative
fluoresencent microscopic images of NETs (red arrows) induced by WT
GAS, ΔPil mutant, ΔPil+Pil complemented mutant strains and c WT
GAS and ΔPil+Pil complemented mutant strains are entrapped to a
greater extent than the ΔPil mutant (P=0.0001 and 0.003, respectively).
d Representative images of FITC-labeled GAS adherent to NETs, with
red arrows highlighting the green bacteria adherent to blue NETs. e WT
GAS (P=0.03) and the ΔPil+Pil complemented mutant (P=0.006) are
killed to a greater extent within NETs than the ΔPil mutant
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